Physician profile
Yung Sim
NPI 1013203686
$715.61
in general payments reported to CMS, 2019-2025
9 companies · $25.09 in 2025
The $25.09 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $231 · 2023: $312 · 2024: $147 · 2025: $25.09.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $484.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $484.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $462.97 | 2021-2025 | Ozempic, Rybelsus, Wegovy |
| Inari Medical, INC. | $73.96 | 2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Boehringer Ingelheim Pharmaceuticals, INC. | $46.58 | 2023 | Jardiance |
| Alexion Pharmaceuticals, INC. | $28.76 | 2023 | Strensiq |
| Medtronic, INC. | $25.11 | 2023 | Intellis Adaptivestim |
| Hologic Sales and Service, LLC | $20.95 | 2023 | Thinprep 2000 Processor, Aptima |
| Pfizer INC. | $20.48 | 2023 | |
| Glaxosmithkline, LLC. | $20.31 | 2023 | Arexvy, Shingrix |
| E.R. Squibb & Sons, L.L.C. | $16.49 | 2023 | Eliquis |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Yung Sim listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.